Adam S. Grossman
President and CEO at ADMA Biologics. Based in Ramsey, New Jersey.
- Rank
- 2842nd of 14,452
- Companies held
- 1
- Largest holding
- ADMA, 100.0% of total
- Latest SEC filing
- Nov 16, 2026
- Listed but not counted
- $7.7M
What the $42.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| ADMA Biologics ADMA Common Stock | Directly | 2,064,777 | $13.34 | $27.5M | 64.4% | Form 4, Nov 16, 2026 |
| ADMA Biologics ADMA Common Stock | Through Areth, LLC | 1,143,426 | $13.34 | $15.3M | 35.6% | Form 4, Nov 16, 2026 |
Share counts are the amounts Adam S. Grossman reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Adam S. Grossman's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| ADMA Biologics ADMA Common Stock | Through Hariden, LLC Held by a company or fund the insider manages | 580,957 | $13.34 | $7.7M | — | Form 4, Nov 16, 2026 |
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Sold | ADMA | 15,000 | $13.72 | $206K | View |
| Nov 16, 2026 | Sold | ADMA | 6,000 | $13.72 | $82K | View |
| Nov 5, 2026 | Sold | ADMA | 105,000 | $12.00 | $1.3M | View |
| Nov 5, 2026 | Sold | ADMA | 42,000 | $12.00 | $504K | View |
| Mar 16, 2026 | Sold | ADMA | 6,000 | $15.16 | $91K | View |
| Mar 16, 2026 | Sold | ADMA | 15,000 | $15.16 | $227K | View |
| Feb 17, 2026 | Sold | ADMA | 6,000 | $16.08 | $96K | View |
| Feb 17, 2026 | Sold | ADMA | 15,000 | $16.08 | $241K | View |
| Dec 15, 2025 | Sold | ADMA | 6,000 | $19.79 | $119K | View |
| Dec 15, 2025 | Sold | ADMA | 15,000 | $19.79 | $297K | View |
| Nov 19, 2025 | Sold | ADMA | 6,000 | $16.00 | $96K | View |
| Nov 19, 2025 | Sold | ADMA | 15,000 | $16.00 | $240K | View |
| Oct 24, 2025 | Sold | ADMA | 15,000 | $16.00 | $240K | View |
| Oct 24, 2025 | Sold | ADMA | 6,000 | $16.00 | $96K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2839 | Barry Schneider Executive Vice President & CTO, Steel Dynamics. Fort Wayne, IN | $42.9M |
| 2840 | Christopher Peetz CHIEF EXECUTIVE OFFICER, Mirum Pharmaceuticals. Foster City, CA | $42.9M |
| 2841 | William L. Williams III Director, Live Oak Bancshares. Wilmington, NC | $42.8M |
| 2842 | Adam S. Grossman President and CEO, ADMA Biologics. Ramsey, NJ | $42.8M |
| 2843 | Paul C. Reilly Executive Chair, Raymond James Financial | $42.8M |
| 2844 | Matthew J. Cox Chairman & CEO, Matson. Honolulu, HI | $42.7M |
| 2845 | Scott J. Vassalluzzo Director, Cimpress. Boca Raton, FL | $42.7M |
Other ADMA Biologics insiders
All ADMA insiders- Brian Lenz$9.4MEVP, CFO. #9222 overall
- Jerrold B. Grossman$7.4MDirector. #11005 overall
- Kaitlin M. Kestenberg-Messina$5.9MCOO and SVP, Compliance. #12916 overall
Questions
How much stock does Adam S. Grossman own?
Adam S. Grossman holds $42,797,428 in listed stock based on SEC filings and current prices, mostly ADMA Biologics (ADMA). That ranks 2842nd on the Stock Rich List.
Is this Adam S. Grossman's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Adam S. Grossman last buy or sell stock?
The most recent open-market trade on file is a sale of 15,000 ADMA shares on Nov 16, 2026 at $13.72.